Drug development is a relay race because you pass the baton to the next runner who will take it to the next level. You are proud to have made it onto the stairs at the end of the race not as an individual but as a huge team of experts of subsequent talents.
In this episode we interview Johannes Fruehauf, Founder and CEO at LabCentral/BioLabs, about how the relay race metaphor shapes our understanding of drug development and why we need knowledgeable capital to forge ahead.
Join us as we discuss:
Solving challenges that face scaling entrepreneurs
The stages of the drug development relay race
Investing in a drug development ecosystem that diversifies talent
The need for investors who understand pharmaceutical startup proposals  


As we continue this journey together, we want to hear from you, the listener. Email [email protected] or [email protected] what’s top of mind, what story you want to hear, or what you find interesting!
To hear more interviews like this one, subscribe to Making Medicine on Apple Podcasts, Spotify, or your preferred podcast platform.
Listening on a desktop & can’t see the links? Just search for Making Medicine in your favorite podcast player.